Comparison of the Profiles of First-Line PD-1/PD-L1 Inhibitors for Advanced NSCLC Lacking Driver Gene Mutations: a Systematic Review and Bayesian Network Meta-Analysis
THERAPEUTIC ADVANCES IN CHRONIC DISEASE（2023）
Key words
bevacizumab,immunotherapy,network meta-analysis,non-small cell lung cancer,PD-1/PD-L1 inhibitors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined